Dr Priscilla Ochuba

Associate Medical Director

Dr Priscilla Ochuba

Dr Priscilla Ochuba provides medical leadership across Richmond Pharmacology's early-phase clinical trials as Associate Medical Director. She supports the safe and effective delivery of complex studies involving both healthy volunteers and patient populations, ensuring the highest standards of participant safety, scientific integrity and clinical excellence.

Priscilla joined Richmond Pharmacology in 2022 as a Clinical Research Physician and has progressed through successive medical leadership roles, becoming Associate Medical Director in 2025. Throughout her time at Richmond, she has played a key role in delivering first-in-human, early, and late phase clinical trials across a broad range of therapeutic areas, combining scientific rigour with a collaborative approach to study delivery.

Before joining Richmond, Priscilla worked within the NHS across several general medical specialities, developing broad clinical expertise and experience caring for diverse patient populations.

Her leadership is centred on participant wellbeing, clinical quality and operational excellence, supporting multidisciplinary teams to deliver innovative clinical research safely and efficiently.

At Richmond Pharmacology, Priscilla is committed to advancing early-phase clinical research through high-quality medical oversight, helping bring innovative therapies to patients while maintaining the highest standards of clinical care.

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event